Why freelance network?

Why freelance?

Because it allows us to get together professionals with extensive experience at competitive pricing.

Why a Network?

Although as professionals we have extensive experience in different areas, the best results are achieved working in a team.

Trialance as a company.

Our company is unique. We work together in a partnership company. We are owners of our company, all of us are shareholders. Medical writing, statisticians and clinical project managers joint together to get the best research projects.

Who contracts?

You always contract a specific professional that will be your direct contact, with no intermediaries.

Cost-effective solution.

We have no offices, all of us work home-based. It is not a trend, it is not for safety. It is for our comfort. It is about saving costs. It is about getting the best efficiency for our clients. It is about getting the best professionals wherever they are.

Where we are?

Where you need, where you like. Our professionals are based in Madrid, Barcelona, Zurich, and Lisbon. We have clients in Europe, LATAM and the USA.

Who are our customers?

Pharma companies, public foundation, scientific societies… from small to big companies based on Spain, Switzerland, the UK, Portugal, Brazil and the USA (2019 and 2020)

What projects are we working on?

From full clinical trials services to specific collaborations. From non-interventional and international patient registries to monitoring phase I studies. From real-world data projects to bibliographic research.

What is different?

We are neither a big nor small CRO, but we work for both small companies and Big Pharma as well as for independent investigators. What makes us different is the proximity to the sponsors and flexibility to adapt to their needs.


Recent publish manuscripts with collaboration of Trialance team

Between 2019 and up to June 2020 we have published 24 international manuscripts with an average impact factor of 4. Some of them:

  • Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term … European Heart Journal, June 2019.
  • Preoperative oral antibiotics and surgical-site infections in colon surgery (ORALEV): a multicenter, single-blind, pragmatic… Lancet Grastroenterol hepathol April 2020
  • Impact of Dual-Chamber Pacing with Closed Loop Stimulation on Quality of Life in Patients with Recurrent Reflex Vasovagal Syncope: results of the SPAIN study Europace, Feb 2020
  • Insulclock: A Novel Insulin Delivery Optimizationand Tracking System. Diabetes Technology & Therapeutics, April 19
  • Clinically Relevant Effect of Rupatadine 20mg and 10mg in Seasonal Allergic Rhinitis: A Pooled Responder Analysis. Clinical and Translational Allergy, October 2019
  • The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors… The Oncologist, February 2020
  • Nebulized hypertonic saline in noncystic fibrosis bronchiectasis: a comprehensive review. Therapeutic Advances in Respiratory Disease, August 2019
  • Recessive Ataxia Differential Diagnosis Algorithm (RADIAL) Versus Specific Niemann-Pick Type C Suspicion Indices: A Retrospective Algorithm Comparison. The Cerebellum, April 2020
  • Clinical management of early-stage cervical cancer: The role of sentinel lymph node biopsy in tumors 2 cm. International Journal of Gynecological Cancer, August 2019
  • A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice. Brain sciences, March 2020

Ongoing clinical trials in different areas

Medical devices, dermatology, oncology, food supplements, autoimmune diseases, cardiology and gynecology.

Clients 2020

Trialance in press

Trialance is the first clinical research firm in Spain incorporated as a cooperative